328 related articles for article (PubMed ID: 11606575)
1. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth.
Bourguignon LY; Zhu H; Zhou B; Diedrich F; Singleton PA; Hung MC
J Biol Chem; 2001 Dec; 276(52):48679-92. PubMed ID: 11606575
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.
Bourguignon LY; Singleton PA; Zhu H; Diedrich F
J Biol Chem; 2003 Aug; 278(32):29420-34. PubMed ID: 12748184
[TBL] [Abstract][Full Text] [Related]
3. CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration.
Bourguignon LY; Zhu H; Shao L; Chen YW
J Biol Chem; 2000 Jan; 275(3):1829-38. PubMed ID: 10636882
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells.
Bourguignon LY; Peyrollier K; Gilad E; Brightman A
J Biol Chem; 2007 Jan; 282(2):1265-80. PubMed ID: 17092940
[TBL] [Abstract][Full Text] [Related]
5. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration.
Bourguignon LY; Zhu H; Shao L; Chen YW
J Biol Chem; 2001 Mar; 276(10):7327-36. PubMed ID: 11084024
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.
Bourguignon LY; Gilad E; Rothman K; Peyrollier K
J Biol Chem; 2005 Mar; 280(12):11961-72. PubMed ID: 15655247
[TBL] [Abstract][Full Text] [Related]
7. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
Bourguignon LY; Gilad E; Peyrollier K
J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
[TBL] [Abstract][Full Text] [Related]
8. Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors.
Smit L; van der Horst G; Borst J
J Biol Chem; 1996 Apr; 271(15):8564-9. PubMed ID: 8621483
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells.
Bourguignon LY; Gilad E; Brightman A; Diedrich F; Singleton P
J Biol Chem; 2006 May; 281(20):14026-40. PubMed ID: 16565089
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
Tanaka M; Gupta R; Mayer BJ
Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
[TBL] [Abstract][Full Text] [Related]
11. The signal transduction through Grb2/Ash in hematopoietic cells.
Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
[TBL] [Abstract][Full Text] [Related]
12. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells.
Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H
Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749
[TBL] [Abstract][Full Text] [Related]
13. Dominant-negative mutants of Grb2 induced reversal of the transformed phenotypes caused by the point mutation-activated rat HER-2/Neu.
Xie Y; Pendergast AM; Hung MC
J Biol Chem; 1995 Dec; 270(51):30717-24. PubMed ID: 8530511
[TBL] [Abstract][Full Text] [Related]
14. A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity.
Cussac D; Vidal M; Leprince C; Liu WQ; Cornille F; Tiraboschi G; Roques BP; Garbay C
FASEB J; 1999 Jan; 13(1):31-8. PubMed ID: 9872927
[TBL] [Abstract][Full Text] [Related]
15. Tight association of GRB2 with receptor protein-tyrosine phosphatase alpha is mediated by the SH2 and C-terminal SH3 domains.
den Hertog J; Hunter T
EMBO J; 1996 Jun; 15(12):3016-27. PubMed ID: 8670803
[TBL] [Abstract][Full Text] [Related]
16. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
Liu BP; Burridge K
Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
[TBL] [Abstract][Full Text] [Related]
17. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
Heo J; Thapar R; Campbell SL
Biochemistry; 2005 May; 44(17):6573-85. PubMed ID: 15850391
[TBL] [Abstract][Full Text] [Related]
18. Vav2 is an activator of Cdc42, Rac1, and RhoA.
Abe K; Rossman KL; Liu B; Ritola KD; Chiang D; Campbell SL; Burridge K; Der CJ
J Biol Chem; 2000 Apr; 275(14):10141-9. PubMed ID: 10744696
[TBL] [Abstract][Full Text] [Related]
19. Dominant-negative mutants of the SH2/SH3 adapters Nck and Grb2 inhibit MAP kinase activation and mesoderm-specific gene induction by eFGF in Xenopus.
Gupta RW; Mayer BJ
Oncogene; 1998 Oct; 17(17):2155-65. PubMed ID: 9811447
[TBL] [Abstract][Full Text] [Related]
20. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation.
Bourguignon LY; Zhu H; Chu A; Iida N; Zhang L; Hung MC
J Biol Chem; 1997 Oct; 272(44):27913-8. PubMed ID: 9346940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]